Co-Founder and CEO at ADmit Therapeutics - Esplugues de Llobregat, Catalunya, Spain
ADmit Therapeutics is a spin off from the Bellvitge Biomedical Research Institute (Barcelona, Spain) focused in the development of an innovative early Alzheimer's disease diagnosis test.